Skip to Main Content

Author Details

Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
1992
50
26
PMIDPaper TitleJournal TitlePublished Year
29779170Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial.Eur J Nutr2019
29779170Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial.Eur J Nutr2019
30173823An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil.J Heart Lung Transplant2018
30173823An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil.J Heart Lung Transplant2018
29183074Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.JAMA2017
28421185Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent <i>Clostridium difficile</i> Infection in a Pediatric Heart Transplant Patient.Front Cardiovasc Med2017
28320072Constitutive androstane receptor regulates the intestinal mucosal response to injury.Br J Pharmacol2017
29183074Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.JAMA2017
28237889Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.Int J Parasitol2017
28421185Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent <i>Clostridium difficile</i> Infection in a Pediatric Heart Transplant Patient.Front Cardiovasc Med2017
28237889Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.Int J Parasitol2017
28320072Constitutive androstane receptor regulates the intestinal mucosal response to injury.Br J Pharmacol2017
27085070Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.Biochim Biophys Acta2016
27091322Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.Am J Gastroenterol2016
26958573Lead Poisoning From a Ceramic Jug Presenting as Recurrent Abdominal Pain and Jaundice.ACG Case Rep J2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
27085070Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.Biochim Biophys Acta2016
27091322Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.Am J Gastroenterol2016
26958573Lead Poisoning From a Ceramic Jug Presenting as Recurrent Abdominal Pain and Jaundice.ACG Case Rep J2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
25110812A novel method to identify fat malabsorption: the Serum Retinyl Palmitate Test.Clin Chim Acta2015
25573177Giardia duodenalis-induced alterations of commensal bacteria kill Caenorhabditis elegans: a new model to study microbial-microbial interactions in the gut.Am J Physiol Gastrointest Liver Physiol2015
26635079Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.BMC Gastroenterol2015
25110812A novel method to identify fat malabsorption: the Serum Retinyl Palmitate Test.Clin Chim Acta2015
26635079Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.BMC Gastroenterol2015
25573177Giardia duodenalis-induced alterations of commensal bacteria kill Caenorhabditis elegans: a new model to study microbial-microbial interactions in the gut.Am J Physiol Gastrointest Liver Physiol2015
25157528Clostridium difficile infection worsens the prognosis of ulcerative colitis.Can J Gastroenterol Hepatol2014
25157528Clostridium difficile infection worsens the prognosis of ulcerative colitis.Can J Gastroenterol Hepatol2014
23454028Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol2013
23896172Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.Gastroenterology2013
23968203VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis.Liver Int2013
23638009Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome.PLoS One2013
23454028Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol2013
23896172Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.Gastroenterology2013
23968203VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis.Liver Int2013
23638009Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome.PLoS One2013
22221818The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.Liver Int2012
22311366Assessment of variables associated with smoking cessation in Crohn's disease.Dig Dis Sci2012
22683238The human gut microbiome: current knowledge, challenges, and future directions.Transl Res2012
22221818The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.Liver Int2012
22683238The human gut microbiome: current knowledge, challenges, and future directions.Transl Res2012
22311366Assessment of variables associated with smoking cessation in Crohn's disease.Dig Dis Sci2012
20872834NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.Inflamm Bowel Dis2011
21206379Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients.J Pediatr Gastroenterol Nutr2011
20872834NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.Inflamm Bowel Dis2011
21765868Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.Therap Adv Gastroenterol2011
21671966Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.Aliment Pharmacol Ther2011
21830275Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.Inflamm Bowel Dis2011
21830275Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.Inflamm Bowel Dis2011
21765868Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.Therap Adv Gastroenterol2011
  • 1 - 50 of 100

Recommended Authors

Jhansi L Leslie
University of Virginia
Career Start Year 2012
Number of shared co-authors 0
Gaurav Syal
university of california san diego
Career Start Year 2012
Number of shared co-authors 1
Suzanne Devkota
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2010
Number of shared co-authors 0
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 0
Berkeley N Limketkai
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Arun Swaminath
Lenox Hill Hospital
Career Start Year 2006
Number of shared co-authors 0
Noah W Palm
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Brigid S Boland
University of California
Career Start Year 2005
Number of shared co-authors 1
Jenny Sauk
university of california los angeles School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Jonathan P Jacobs
David Geffen School of Medicine at university of california los angeles
Career Start Year 2002
Number of shared co-authors 1
Eran Elinav
German Cancer Research Center
Career Start Year 2002
Number of shared co-authors 1
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 0
Dana J Lukin
Jill Roberts Center for IBD
Career Start Year 2000
Number of shared co-authors 0
Bruce A Vallance
B.C. Children's Hospital
Career Start Year 1997
Number of shared co-authors 0
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 1
Edward V Loftus
Mayo Clinic College of Medicine and Science
Career Start Year 1994
Number of shared co-authors 0
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 1
Steven F Moss
Brown University, Rhode Island Providence VA Medical Center
Career Start Year 1991
Number of shared co-authors 0
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 1
Danielle K Turgeon
The University of Michigan ann arbor
Career Start Year 1990
Number of shared co-authors 0
Sunanda V Kane
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 0
Vincent B Young
University of Michigan ann arbor
Career Start Year 1986
Number of shared co-authors 0
Mitchell B Cohen
University of Alabama at Birmingham
Career Start Year 1986
Number of shared co-authors 0
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 3
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Career Start Year 1984
Number of shared co-authors 2
Nicholas J Talley
University of Newcastle
Career Start Year 1984
Number of shared co-authors 0
Samuel B Ho
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Career Start Year 1983
Number of shared co-authors 0
Ryan Balfour Sartor
University of North Carolina at Chapel Hill
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Steven C Greenway
Co-authored papers 2
Haran Sivakumaran
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Wendy S Rubinstein
CancerLinQ LLC, American Society of Clinical Oncology
Co-authored papers 1
Kerry Phillips
Royal Adelaide Hospital
Co-authored papers 1
Lyn Schofield
King Edward Memorial Hospital for Women Perth
Co-authored papers 1
Jason S Lee
QIMR Berghofer Medical Research Institute
Co-authored papers 1
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 1
Noralane M Lindor
Mayo Clinic
Co-authored papers 1
Peter J Hulick
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Co-authored papers 1
Jone E Sampson
Oregon Health & Science University
Co-authored papers 1
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 1
David E Goldgar
University of Utah
Co-authored papers 1
Jacqueline Armstrong
SA Pathology at the Women's and Children's Hospital
Co-authored papers 1
Stacey L Edwards
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Sunil R Lakhani
University of Queensland
Co-authored papers 1
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Alireza Heravi-Moussavi
Ferdowsi University of Mashhad
Co-authored papers 1
Pavel N Pichurin
Mayo Clinic
Co-authored papers 1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Juliet D French
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Daniel L Worthley
South Australian Health and Medical Research Institute
Co-authored papers 1
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Lachlan J M Coin
The Peter Doherty Institute for Infection and Immunity, The University of Melbourne
Co-authored papers 1
Geoffrey J Faulkner
Mater Research Institute - University of Queensland
Co-authored papers 1
Kathleen A Calzone
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Co-authored papers 1
Ramnik J Xavier
Broad Institute of MIT and Harvard
Co-authored papers 1
Anna Newlin
NorthShore University HealthSystem
Co-authored papers 1
Release 1.2